NCT04168398View on ClinicalTrials.gov

Clopidogrel Aspirin Therapy (CAT) Versus Apixiban Aspirin Therapy (AAT) After Lower Limb Revascularization

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

1,536

Participants

Timeline

Start Date

July 3, 2019

Primary Completion Date

November 1, 2021

Study Completion Date

November 3, 2021

Conditions
IschemiaAnticoagulants
Interventions
DRUG

Combination drug

Anticoagulation

Trial Locations (1)

35111

Mansoura, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT04168398 - Clopidogrel Aspirin Therapy (CAT) Versus Apixiban Aspirin Therapy (AAT) After Lower Limb Revascularization | Biotech Hunter | Biotech Hunter